4ABBV
AbbVie, Inc. · EUROTLX:4ABBV
265.20 EUR6.00 +2.31%
AbbVie, Inc. (EUROTLX:4ABBV) last traded at 265.20 EUR, up 2.31% on the day. Over the past year the stock is up 34.35%. Its 52-week range is 168.90 to 265.20. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open265.20
Day range265.20 – 265.20
52-week range168.90 – 265.20
Volume0
Average volume (10 days)0
Market cap (USD)521.11 B
P/E51.64
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)−0.3191
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+4.12%1 week
+14.02%1 month
+20.05%3 months
+46.08%6 months
+35.44%Year to date
+34.35%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
271.11 EUR
The average 1-year price target, +2.23% from the last price. See the forecast
Latest headlines
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
- What AbbVie (ABBV) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.